Pathways Neuro Pharma, Inc.
Home
Solutions
  • Juvenile Parkinson's
  • Intellectual Property
Science
  • Gene Therapy
  • Pharmaceutical Discovery
About
Contact
NEWS
  • Press Releases & Podcasts
  • Papers & Presentations
Pathways Neuro Pharma, Inc.
Home
Solutions
  • Juvenile Parkinson's
  • Intellectual Property
Science
  • Gene Therapy
  • Pharmaceutical Discovery
About
Contact
NEWS
  • Press Releases & Podcasts
  • Papers & Presentations
More
  • Home
  • Solutions
    • Juvenile Parkinson's
    • Intellectual Property
  • Science
    • Gene Therapy
    • Pharmaceutical Discovery
  • About
  • Contact
  • NEWS
    • Press Releases & Podcasts
    • Papers & Presentations
  • Home
  • Solutions
    • Juvenile Parkinson's
    • Intellectual Property
  • Science
    • Gene Therapy
    • Pharmaceutical Discovery
  • About
  • Contact
  • NEWS
    • Press Releases & Podcasts
    • Papers & Presentations

INtellectual Property

  

“Composition and Endogenous Production of siRNA and miRNA Targeting mRNA of Checkpoint Protein Precursors”

US Patent Application Number 16/419,874

Filed May 22, 2019


“Compositions and Methods for Regulating Production of a Precursor Protein”

US Patent Application Number 17/105,967

Filed Nov 27, 2020


“Neuroreceptor Compositions and Methods Of Use”

US Patent Application Number 17/190,322

Filed March 2, 2021


Subscribe

Copyright © 2024 PathwaysNP,  

18205 Burkhardt Road, Tomball, Texas 77377, United States

  - All Rights Reserved.

  • Home
  • Juvenile Parkinson's
  • Gene Therapy
  • Pharmaceutical Discovery
  • Contact
  • Press Releases & Podcasts
  • Papers & Presentations

Powered by